TSPO and central nervous system cancer: Several studies confirmed the upregulation of Translocator protein (TSPO) in gliomas, and a recent study by Su et al. reported the use of [11C]PK11195 radiotracer can be easily differentiated between the low-grade astrocytomas and oligodendrogliomas through a PET dynamic study (108).